Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report 2026
Download Free Sample Buy Now
Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report 2026

Global Outlook – By Product (Small Molecules, Large Molecules), By Formulation Type (Solid Formulations, Liquid Formulations, Injectable Formulations), By Service Type (Clinical Trial Material Supply, Regulatory Support Services, Manufacturing Services), By End-User (Biotechnology Companies, Academic And Research Institutes, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

• Investigational New Drug Contract Development And Manufacturing Organization (CDMO) market size has reached to $5.91 billion in 2025

• Expected to grow to $8.17 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%

• Growth Driver: Increase In Clinical Trials Fueling The Growth Of The Market Due To Rising Demand For Innovative Treatments

• Market Trend: Sartorius And Repligen Form Strategic Partnership To Advance Upstream Bioprocessing

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?

An investigational new drug contract development and manufacturing organization (CDMO) refers to a contract development and manufacturing organization that supports the development and production of pharmaceutical compounds intended for use in clinical trials under an Investigational New Drug application. These organizations operate within the regulatory frameworks required for early-stage drug development, ensuring compliance with guidelines necessary for advancing experimental therapies toward market approval.

The main products of investigational new drug contract development and manufacturing organization (CDMO) include small molecules and large molecules. Small molecules refer to low molecular weight compounds that can easily penetrate cell membranes and interact with intracellular targets to influence biological processes. It is used for various formulations, such as solid formulations, liquid formulations, and injectable formulations, and offers different services, including preclinical services, clinical trial material supply, regulatory support services, and manufacturing services. It is used by several end-users, including pharmaceutical companies, biotechnology companies, academic and research institutes, and others.

Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Global Report 2026 Market Report bar graph

What Is The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size and Share 2026?

The investigational new drug contract development and manufacturing organization (cdmo) market size has grown strongly in recent years. It will grow from $5.91 billion in 2025 to $6.33 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to limited availability of cdmos for investigational drugs, growing demand for small molecule synthesis, reliance on conventional manufacturing services, increasing clinical trial volumes, early adoption of regulatory support services.

What Is The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Growth Forecast?

The investigational new drug contract development and manufacturing organization (cdmo) market size is expected to see strong growth in the next few years. It will grow to $8.17 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to expansion of gene and cell therapy manufacturing capabilities, rising demand for monoclonal antibodies and recombinant proteins, investment in advanced formulation technologies, adoption of scalable manufacturing platforms, growth in global biotechnology research collaborations. Major trends in the forecast period include rising demand for early-stage drug development services, growth in clinical trial material supply services, increasing focus on regulatory compliance and quality standards, expansion of biologics and advanced therapy development, adoption of custom manufacturing solutions for small and large molecules.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Segmentation

1) By Product: Small Molecules, Large Molecules

2) By Formulation Type: Solid Formulations, Liquid Formulations, Injectable Formulations

3) By Service Type: Clinical Trial Material Supply, Regulatory Support Services, Manufacturing Services

4) By End-User: Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Small Molecules: Synthetic Small Molecules, Semi-synthetic Small Molecules, Peptide-based Small Molecules, Oligonucleotides

2) By Large Molecules: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Cell Therapy Products, Gene Therapy Products, RNA-based Therapeutics

What Is The Driver Of The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?

The rising clinical trials are expected to propel the growth of the investigational new drug contract development and manufacturing organization (CDMO) market going forward. Clinical trials are carefully designed studies involving human participants to test how safe and effective a medical treatment, procedure, or intervention is under controlled conditions. The rise in clinical trials is largely driven by the growing demand for innovative treatments, as increasing rates of chronic and complex diseases push pharmaceutical and biotech companies to develop and test new therapies. Investigational new drug CDMOs support clinical trials by streamlining the development and manufacturing of trial-ready drug formulations, ensuring a timely and compliant supply of investigational products for each study phase. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based pharmaceutical industry trade association, the total number of industry-sponsored clinical trials initiated in the United Kingdom increased from 411 in 2022 to 426 in 2023, while Phase III trial initiations grew by 16.5 percent over the same period, rising from 182 to 212. Therefore, the rising clinical trials are driving the growth of the investigational new drug contract development and manufacturing organization (CDMO) industry.

Key Players In The Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

Major companies operating in the investigational new drug contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., Amaran Biotech Inc.

Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Trends and Insights

Major companies operating in the investigational new drug contract development and manufacturing organization (CDMO) market are focusing on strategic partnerships to strengthen development capabilities and speed up clinical entry. Strategic partnerships refer to formal alliances between two or more organizations that collaborate to achieve shared objectives, leveraging each other’s strengths, resources, or expertise to gain mutual benefits while remaining independent entities. For instance, in August 2023, Sartorius AG, a Germany-based life science company, partnered with Repligen Corporation, a US-based life sciences company, to launch an integrated system combining the BIOSTAT STR and XCell ATF technologies for upstream process intensification. This collaboration aims to streamline biopharmaceutical production by enhancing efficiency and scalability. The initiative marks Sartorius’ continued innovation in bioprocessing solutions, reinforcing its commitment to advancing the biomanufacturing industry.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?

In January 2024, Alcami Corporation, a US-based pharmaceutical contract development and manufacturing organization (CDMO), acquired Pacific Pharmaceutical Services for an undisclosed amount. Through this acquisition, Alcami aims to expand its West Coast presence and enhance its analytical testing and quality control capabilities. Pacific Pharmaceutical Services is a US-based company providing pharmaceutical testing and quality assurance services.

Regional Insights

North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?

The investigational new drug contract development and manufacturing organization (CDMO) market includes revenues earned by entities through analytical method development, clinical trial material manufacturing, process development, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report 2026?

The investigational new drug contract development and manufacturing organization (cdmo) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the investigational new drug contract development and manufacturing organization (cdmo) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $6.33 billion
Revenue Forecast In 2035 $8.17 billion
Growth Rate CAGR of 7.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Formulation Type, Service Type, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Gra
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Demand For Early-Stage Drug Development Services

4.2.2 Growth In Clinical Trial Material Supply Services

4.2.3 Increasing Focus On Regulatory Compliance And Quality Standards

4.2.4 Expansion Of Biologics And Advanced Therapy Development

4.2.5 Adoption Of Custom Manufacturing Solutions For Small And Large Molecules

5. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Analysis Of End Use Industries

5.1 Biotechnology Companies

5.2 Pharmaceutical Companies

5.3 Academic And Research Institutes

5.4 Contract Research Organizations (Cros)

5.5 Hospitals And Clinics

6. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Segmentation

9.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Molecules, Large Molecules

9.2. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Solid Formulations, Liquid Formulations, Injectable Formulations

9.3. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinical Trial Material Supply, Regulatory Support Services, Manufacturing Services

9.4. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biotechnology Companies, Academic And Research Institutes, Other End-Users

9.5. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Synthetic Small Molecules, Semi-synthetic Small Molecules, Peptide-based Small Molecules, Oligonucleotides

9.6. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Large Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Cell Therapy Products, Gene Therapy Products, RNA-based Therapeutics

10. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

10.1. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

11.1. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

12.1. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

13.1. India Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

14.1. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

15.1. Australia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

16.1. Indonesia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

17.1. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

18.1. Taiwan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

19.1. South East Asia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

20.1. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

21.1. UK Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

22.1. Germany Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

23.1. France Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

24.1. Italy Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

25.1. Spain Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

26.1. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

27.1. Russia Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

28.1. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

29.1. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

30.1. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

31.1. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

32.1. Brazil Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

33.1. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

34.1. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Formulation Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Regulatory and Investment Landscape

36. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

36.1. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Samsung Biologics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., Amaran Biotech Inc.

38. Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market

40. Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

40.1 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Countries Offering Most New Opportunities

40.2 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Segments Offering Most New Opportunities

40.3 Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Overview Of Key Products - Product Examples
  • Table 2: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Supply Chain Analysis
  • Table 4: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Raw Material Providers
  • Table 5: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Resource Providers
  • Table 6: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Manufacturers (Suppliers)
  • Table 7: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Distributors And Channel Partners
  • Table 8: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Key Technologies & Future Trends
  • Table 9: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Trends
  • Table 10: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major End Users
  • Table 11: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market - TAM, US$ Billion, 2025
  • Table 15: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Large Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia , Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia , Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia , Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market - Company Scoring Matrix
  • Table 97: Thermo Fisher Scientific Inc. Financial Performance
  • Table 98: Fresenius Kabi AG Financial Performance
  • Table 99: Lonza Group Ltd. Financial Performance
  • Table 100: Catalent Inc. Financial Performance
  • Table 101: Samsung Biologics Co. Ltd. Financial Performance
  • Table 102: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Competitive Dashboard
  • Table 104: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 106: Global, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Formulation Type, 2025 – 2030
  • Table 107: Global, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Service Type, 2025 – 2030

List Of Figures

    Figure 1: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Supply Chain Analysis
  • Figure 4: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Raw Material Providers
  • Figure 5: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Resource Providers
  • Figure 6: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Distributors And Channel Partners
  • Figure 8: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Key Technologies & Future Trends
  • Figure 9: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major Trends
  • Figure 10: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Major End Users
  • Figure 11: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market - TAM, US$ Billion, 2025
  • Figure 15: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Large Molecules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia , Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia , Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia , Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market - Company Scoring Matrix
  • Figure 97: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 98: Fresenius Kabi AG Financial Performance
  • Figure 99: Lonza Group Ltd. Financial Performance
  • Figure 100: Catalent Inc. Financial Performance
  • Figure 101: Samsung Biologics Co. Ltd. Financial Performance
  • Figure 102: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market, Competitive Dashboard
  • Figure 104: Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 106: Global, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Formulation Type, 2025 – 2030
  • Figure 107: Global, Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Service Type, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report 2026 - Global Outlook – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase ...

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product Type (Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products...

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product (Gene Therapy, Cell Therapy, Tissue Engineered), By Phase (Phase I, Phase II...

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Phase (Phase 1, Phase 2,...

Biopharmaceuticals Contract Manufacturing Market Report 2026 - Global Outlook – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAI, And Molecular Therapy, Biosimilars), B...

Pharmaceutical Contract Packaging Market Report 2026 - Global Outlook – By Product (Primary Packaging, Secondary Packaging, Tertiary Packaging ), By Material (Paper And Paperboard, Plastics And Polymers, Aluminum Foil, G...

Medical Device Contract Research Organization Market Report 2026 - Global Outlook – By Type (Finished Medical Devices, Medical Device Semi Finished Products, Medical Device Raw Materials), By Device Class (Class 1, Class...

Biologics Contract Development Market Report 2026 - Global Outlook – By Source (Microbial, Mammalian, Other Sources), By Indication (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, O...

Frequently Asked Questions

The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) market was valued at $5.91 billion in 2025, increased to $6.33 billion in 2026, and is projected to reach $8.17 billion by 2030.

The global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) market is expected to grow at a CAGR of 6.6% from 2026 to 2035 to reach $8.17 billion by 2035.

Some Key Players in the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) market Include, Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., Amaran Biotech Inc. .

Major trend in this market includes: Sartorius And Repligen Form Strategic Partnership To Advance Upstream Bioprocessing. For further insights on this market. request a sample here

North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the investigational new drug contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us